Novel MicroRNA Regulators of Atrial Natriuretic Peptide Production

REFERENCES

• Volpe M, Rubattu S, Burnett J, Jr. 2014. Natriuretic peptides in cardiovascular diseases: current use and perspectives. Eur Heart J 35:419–425. http://dx.doi.org/10.1093/eurheartj/eht466.
   PubMed Web of Science ®Google Scholar
• McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR. 2014. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371:993–1004. http://dx.doi.org/10.1056/NEJMoa1409077.
   PubMed Web of Science ®Google Scholar
• Potter LR. 2011. Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases. Pharmacol Ther 130:71–82. http://dx.doi.org/10.1016/j.pharmthera.2010.12.005.
   PubMed Web of Science ®Google Scholar
• Steinhelper ME, Cochrane KL, Field LJ. 1990. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension 16:301–307. http://dx.doi.org/10.1161/01.HYP.16.3.301.
   PubMed Web of Science ®Google Scholar
• John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O. 1995. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267:679–681. http://dx.doi.org/10.1126/science.7839143.
   PubMed Web of Science ®Google Scholar
• Newton-Cheh C, Larson MG, Vasan RS, Levy D, Bloch KD, Surti A, Guiducci C, Kathiresan S, Benjamin EJ, Struck J, Morgenthaler NG, Bergmann A, Blankenberg S, Kee F, Nilsson P, Yin X, Peltonen L, Vartiainen E, Salomaa V, Hirschhorn JN, Melander O, Wang TJ. 2009. Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet 41:348–353. http://dx.doi.org/10.1038/ng.328.
   PubMed Web of Science ®Google Scholar
• Arora P, Wu C, Khan AM, Bloch DB, Davis-Dusenbery BN, Ghorbani A, Spagnolli E, Martinez A, Ryan A, Tainsh LT, Kim S, Rong J, Huan T, Freedman JE, Levy D, Miller KK, Hata A, Del Monte F, Vandenwijngaert S, Swinnen M, Janssens S, Holmes TM, Buys ES, Bloch KD, Newton-Cheh C, Wang TJ. 2013. Atrial natriuretic peptide is negatively regulated by microRNA-425. J Clin Invest 123:3378–3382. http://dx.doi.org/10.1172/JCI67383.
   PubMed Web of Science ®Google Scholar
• Balaga O, Friedman Y, Linial M. 2012. Toward a combinatorial nature of microRNA regulation in human cells. Nucleic Acids Res 40:9404–9416. http://dx.doi.org/10.1093/nar/gks759.
   PubMedGoogle Scholar
• Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N. 2005. Combinatorial microRNA target predictions. Nat Genet 37:495–500. http://dx.doi.org/10.1038/ng1536.
   PubMed Web of Science ®Google Scholar
• Akbari Moqadam F, Pieters R, den Boer ML. 2013. The hunting of targets: challenge in miRNA research. Leukemia 27:16–23. http://dx.doi.org/10.1038/leu.2012.179.
   PubMed Web of Science ®Google Scholar
• Shirdel EA, Xie W, Mak TW, Jurisica I. 2011. NAViGaTing the micronome—using multiple microRNA prediction databases to identify signalling pathway-associated microRNAs. PLoS One 6:e17429. http://dx.doi.org/10.1371/journal.pone.0017429.
   PubMed Web of Science ®Google Scholar
• Lian X, Hsiao C, Wilson G, Zhu K, Hazeltine LB, Azarin SM, Raval KK, Zhang J, Kamp TJ, Palecek SP. 2012. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A 109:E1848–E1857. http://dx.doi.org/10.1073/pnas.1200250109.
   PubMed Web of Science ®Google Scholar
• Smith JG, Newton-Cheh C, Almgren P, Struck J, Morgenthaler NG, Bergmann A, Platonov PG, Hedblad B, Engstrom G, Wang TJ, Melander O. 2010. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. J Am Coll Cardiol 56:1712–1719. http://dx.doi.org/10.1016/j.jacc.2010.05.049.
   PubMed Web of Science ®Google Scholar
• van Rooij E. 2011. The art of microRNA research. Circ Res 108:219–234. http://dx.doi.org/10.1161/CIRCRESAHA.110.227496.
   PubMed Web of Science ®Google Scholar
• Hsu J, Hanna P, Van Wagoner DR, Barnard J, Serre D, Chung MK, Smith JD. 2012. Whole genome expression differences in human left and right atria ascertained by RNA sequencing. Circ Cardiovasc Genet 5:327–335. http://dx.doi.org/10.1161/CIRCGENETICS.111.961631.
   PubMedGoogle Scholar
• Doench JG, Sharp PA. 2004. Specificity of microRNA target selection in translational repression. Genes Dev 18:504–511. http://dx.doi.org/10.1101/gad.1184404.
   PubMed Web of Science ®Google Scholar
• Yue D, Liu H, Huang Y. 2009. Survey of computational algorithms for microRNA target prediction. Curr Genomics 10:478–492. http://dx.doi.org/10.2174/138920209789208219.
   PubMedGoogle Scholar
• Brennecke J, Stark A, Russell RB, Cohen SM. 2005. Principles of microRNA-target recognition. PLoS Biol 3:e85. http://dx.doi.org/10.1371/journal.pbio.0030085.
   PubMed Web of Science ®Google Scholar
• Karbiener M, Glantschnig C, Scheideler M. 2014. Hunting the needle in the haystack: a guide to obtain biologically meaningful microRNA targets. Int J Mol Sci 15:20266–20289. http://dx.doi.org/10.3390/ijms151120266.
   PubMedGoogle Scholar
• Jiang Q, Feng MG, Mo YY. 2009. Systematic validation of predicted microRNAs for cyclin D1. BMC Cancer 9:194. http://dx.doi.org/10.1186/1471-2407-9-194.
   PubMed Web of Science ®Google Scholar
• Long D, Lee R, Williams P, Chan CY, Ambros V, Ding Y. 2007. Potent effect of target structure on microRNA function. Nat Struct Mol Biol 14:287–294. http://dx.doi.org/10.1038/nsmb1226.
   PubMed Web of Science ®Google Scholar
• Li F, Zheng Q, Ryvkin P, Dragomir I, Desai Y, Aiyer S, Valladares O, Yang J, Bambina S, Sabin LR, Murray JI, Lamitina T, Raj A, Cherry S, Wang LS, Gregory BD. 2012. Global analysis of RNA secondary structure in two metazoans. Cell Rep 1:69–82. http://dx.doi.org/10.1016/j.celrep.2011.10.002.
   PubMed Web of Science ®Google Scholar
• Kedde M, Strasser MJ, Boldajipour B, Oude Vrielink JA, Slanchev K, le Sage C, Nagel R, Voorhoeve PM, van Duijse J, Orom UA, Lund AH, Perrakis A, Raz E, Agami R. 2007. RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell 131:1273–1286. http://dx.doi.org/10.1016/j.cell.2007.11.034.
   PubMed Web of Science ®Google Scholar
• Beillard E, Ong SC, Giannakakis A, Guccione E, Vardy LA, Voorhoeve PM. 2012. miR-Sens—a retroviral dual-luciferase reporter to detect microRNA activity in primary cells. RNA 18:1091–1100. http://dx.doi.org/10.1261/rna.031831.111.
   PubMed Web of Science ®Google Scholar
• Gentner B, Schira G, Giustacchini A, Amendola M, Brown BD, Ponzoni M, Naldini L. 2009. Stable knockdown of microRNA in vivo by lentiviral vectors. Nat Methods 6:63–66. http://dx.doi.org/10.1038/nmeth.1277.
   PubMed Web of Science ®Google Scholar
• Brown BD, Naldini L. 2009. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat Rev Genet 10:578–585. http://dx.doi.org/10.1038/nrg2628.
   PubMed Web of Science ®Google Scholar
• Wang G, van der Walt JM, Mayhew G, Li YJ, Zuchner S, Scott WK, Martin ER, Vance JM. 2008. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet 82:283–289. http://dx.doi.org/10.1016/j.ajhg.2007.09.021.
   PubMed Web of Science ®Google Scholar
• Seok HY, Chen J, Kataoka M, Huang ZP, Ding J, Yan J, Hu X, Wang DZ. 2014. Loss of microRNA-155 protects the heart from pathological cardiac hypertrophy. Circ Res 114:1585–1595. http://dx.doi.org/10.1161/CIRCRESAHA.114.303784.
   PubMed Web of Science ®Google Scholar
• Heymans S, Corsten MF, Verhesen W, Carai P, van Leeuwen RE, Custers K, Peters T, Hazebroek M, Stoger L, Wijnands E, Janssen BJ, Creemers EE, Pinto YM, Grimm D, Schurmann N, Vigorito E, Thum T, Stassen F, Yin X, Mayr M, de Windt LJ, Lutgens E, Wouters K, de Winther MP, Zacchigna S, Giacca M, van Bilsen M, Papageorgiou AP, Schroen B. 2013. Macrophage microRNA-155 promotes cardiac hypertrophy and failure. Circulation 128:1420–1432. http://dx.doi.org/10.1161/CIRCULATIONAHA.112.001357.
   PubMed Web of Science ®Google Scholar
• Faraoni I, Antonetti FR, Cardone J, Bonmassar E. 2009. miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 1792:497–505. http://dx.doi.org/10.1016/j.bbadis.2009.02.013.
   PubMed Web of Science ®Google Scholar
• Mitcheson JS, Hancox JC, Levi AJ. 1998. Cultured adult cardiac myocytes: future applications, culture methods, morphological and electrophysiological properties. Cardiovasc Res 39:280–300. http://dx.doi.org/10.1016/S0008-6363(98)00128-X.
   PubMed Web of Science ®Google Scholar
• Harding SE, Ali NN, Brito-Martins M, Gorelik J. 2007. The human embryonic stem cell-derived cardiomyocyte as a pharmacological model. Pharmacol Ther 113:341–353. http://dx.doi.org/10.1016/j.pharmthera.2006.08.008.
   PubMed Web of Science ®Google Scholar
• Dick E, Rajamohan D, Ronksley J, Denning C. 2010. Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening. Biochem Soc Trans 38:1037–1045. http://dx.doi.org/10.1042/BST0381037.
   PubMed Web of Science ®Google Scholar
• Synnergren J, Ameen C, Lindahl A, Olsson B, Sartipy P. 2011. Expression of microRNAs and their target mRNAs in human stem cell-derived cardiomyocyte clusters and in heart tissue. Physiol Genomics 43:581–594. http://dx.doi.org/10.1152/physiolgenomics.00074.2010.
   PubMedGoogle Scholar
• Puppala D, Collis LP, Sun SZ, Bonato V, Chen X, Anson B, Pletcher M, Fermini B, Engle SJ. 2013. Comparative gene expression profiling in human-induced pluripotent stem cell–derived cardiocytes and human and cynomolgus heart tissue. Toxicol Sci 131:292–301. http://dx.doi.org/10.1093/toxsci/kfs282.
   PubMedGoogle Scholar
• Babiarz JE, Ravon M, Sridhar S, Ravindran P, Swanson B, Bitter H, Weiser T, Chiao E, Certa U, Kolaja KL. 2012. Determination of the human cardiomyocyte mRNA and miRNA differentiation network by fine-scale profiling. Stem Cells Dev 21:1956–1965. http://dx.doi.org/10.1089/scd.2011.0357.
   PubMed Web of Science ®Google Scholar